GeoVax Labs Faces Delisting Concerns

TL;DR

GeoVax Labs might get delisted, big trouble for the stock.

AI Summary

GeoVax Labs, Inc. filed an 8-K on May 24, 2024, to report a notice of delisting or failure to satisfy a continued listing rule. The company is based in Smyrna, Georgia, and its fiscal year ends on December 31.

Why It Matters

This filing indicates potential issues with GeoVax Labs' continued listing on an exchange, which could impact its stock trading and investor confidence.

Risk Assessment

Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's ability to remain publicly traded.

Key Numbers

• 001-39563 — Commission File Number (Identifies the company's filing with the SEC)
• 87-0455038 — IRS Employer Identification Number (Company's tax identification number)

Key Players & Entities

• GeoVax Labs, Inc. (company) — Registrant
• May 23, 2024 (date) — Date of earliest event reported
• May 24, 2024 (date) — Filing date
• Smyrna, Georgia (location) — Company business address

FAQ

Key Financial Figures

• $0.001 — ch registered Common Stock , par value $0.001 per share GOVX The Nasdaq Capital Ma
• $2,500,000 m — any that it no longer complies with the $2,500,000 minimum stockholders' equity required for

Filing Documents

• govx20240524_8k.htm (8-K) — 29KB
• 0001437749-24-018321.txt ( ) — 177KB
• govx-20240523.xsd (EX-101.SCH) — 4KB
• govx-20240523_def.xml (EX-101.DEF) — 13KB
• govx-20240523_lab.xml (EX-101.LAB) — 18KB
• govx-20240523_pre.xml (EX-101.PRE) — 13KB
• govx20240524_8k_htm.xml (XML) — 5KB

01

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On May 23, 2024, the Company received a notice (the "Notice") from the Listing Qualifications Department (the "Staff") of the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it no longer complies with the $2,500,000 minimum stockholders' equity required for continued listing pursuant to Nasdaq Listing Rule 5550(b)(1) (the "Stockholders' Equity Requirement"), because the Company's stockholders' equity as reported in its Form 10-Q for the period ended March 31, 2024 did not meet the required minimum, and as of the date of the Notice, the Company did not meet the alternatives of market value of listed securities or net income from continuing operations (together with the Stockholders' Equity Requirement, the "Listing Rule"). In accordance with Nasdaq Listing Rules, the Company has 45 calendar days, or until July 8, 2024, to submit a plan to regain compliance to Nasdaq. If the plan is accepted, the Staff may grant the Company an extension period of up to 180 calendar days from the date of the Notice to evidence compliance. The notification received has no immediate effect on the Company's Nasdaq listing. The Company's common stock will continue to trade on Nasdaq under the symbol "GOVX" at this time. The Company intends to submit a plan to regain compliance. The Company is currently evaluating its options for regaining compliance. There can be no assurance that the Staff will accept the Company's plan to regain compliance with the Listing Rule or, if accepted, that the Company will evidence compliance with the Listing Rule during any extension period that the Staff may grant. If the Staff does not accept the Company's plan or if the Company is unable to regain compliance within any extension period granted by the Staff, the Staff would be required to issue a delisting determination. The Company would at that time be entitled to request a hea

View Full Filing

View this 8-K filing on SEC EDGAR